Wolbaki

Guangzhou Wolbaki Biotech is a leading biotechnology company specializing in the biocontrol of insect pests and the prevention of mosquito-borne diseases. Founded in 2015 by Professor Zhiyong Xi, the company operates the world's largest 'mosquito factory' in Guangzhou, China, with a production capacity of up to 60 million male mosquitoes per week. Wolbaki utilizes the symbiotic bacterium Wolbachia to induce cytoplasmic incompatibility, a process that prevents wild mosquito eggs from hatching, thereby suppressing populations of Aedes aegypti and Aedes albopictus. This environmentally friendly technology effectively blocks the transmission of human pathogens such as dengue, Zika, and chikungunya viruses. The company's innovative approach has been validated through extensive field trials and is currently being deployed in various global regions to protect public health and agricultural productivity.